CDEK
← All organizations

NX Development Corp.

For profitWebsite ↗

Also known as: NXDC | NX Development Corp

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Apr 1, 2020

First marketed drug

Jun 6, 2017

Last known activity

Dec 31, 2025

Timeline

2010s

  1. Jun 1, 2010

    NX Development Corp.— Founded

  2. Jun 6, 2017

    aminolevulinic acid— NDA Secondary Org

Drugs by trial phase (1 distinct, 4 trials)

Phase 3 (1 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (5)

Details

Founded
Louisville, KY, US Jun 1, 2010
Last known activity
Dec 31, 2025